The parent of a child who wore the device to manage diabetes described failed alerts and inaccurate readings in a complaint.
We came across a bearish thesis on DexCom, Inc. on Hunterbrook’s Substack. In this article, we will summarize the bulls’ ...
DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ rating on the stock and a $106 price target. The research firm reiterated ...
Zacks Investment Research on MSN
DexCom (DXCM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
DexCom (DXCM) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the ...
DexCom’s shares are quite volatile and have had 15 moves greater than 5% over the last year. In that context, today’s move ...
Investing.com - TD Cowen reiterated its Buy rating and $100.00 price target on DexCom (NASDAQ:DXCM) on Thursday, citing resolution of earlier issues with the company’s G7 continuous glucose monitoring ...
It is hoped the "groundbreaking" device will help improve treatment options for people with eczema, as STV Reporter Amie Flett reports. For years, people living with ...
The chief technology officer and co-founder explained the technology and design choices that went into Biolinq’s device, ...
A class action lawsuit has been filed against Dexcom (Nasdaq:DXCM) in the U.S. District Court for the Central District of California.
Digital Camera World on MSN
“My Nikon Z8’s sensor is filthy – I had no idea it had a sensor shield!” Here’s how to make sure yours is switched on
Make sure you don’t make the same mistake by ensuring your Nikon Z8 or Z9’s sensor shield is active BEFORE you change lenses ...
Thur 2 Oct 2.13pm • Scientists at Heriot-Watt University in Edinburgh believe they've developed new technology that could revolutionise how eczema is diagnosed and treated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback